These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11390628)

  • 21. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
    Li L; Su X; Choi GC; Cao Y; Ambinder RF; Tao Q
    BMC Cancer; 2012 Mar; 12():125. PubMed ID: 22458933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.
    Liu C; Sista ND; Pagano JS
    J Virol; 1996 Apr; 70(4):2545-55. PubMed ID: 8642684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoter.
    Ho CH; Hsu CF; Fong PF; Tai SK; Hsieh SL; Chen CJ
    J Virol; 2007 May; 81(9):4837-47. PubMed ID: 17301127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple roles of Epstein-Barr virus SM protein in lytic replication.
    Han Z; Marendy E; Wang YD; Yuan J; Sample JT; Swaminathan S
    J Virol; 2007 Apr; 81(8):4058-69. PubMed ID: 17287267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1.
    Li Y; Mahajan NP; Webster-Cyriaque J; Bhende P; Hong GK; Earp HS; Kenney S
    J Virol; 2004 Nov; 78(21):11778-85. PubMed ID: 15479819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
    Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
    Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.
    Zalani S; Holley-Guthrie E; Kenney S
    J Virol; 1995 Jun; 69(6):3816-23. PubMed ID: 7745729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repression by RAZ of Epstein-Barr virus bZIP transcription factor EB1 is dimerization independent.
    Segouffin C; Gruffat H; Sergeant A
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1529-36. PubMed ID: 8757996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.
    Ragoczy T; Miller G
    J Virol; 2001 Jun; 75(11):5240-51. PubMed ID: 11333906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRLF1-dependent viral and cellular transcriptomes and transcriptional regulation during EBV primary infection in B lymphoma cells.
    Long X; Yang Z; Li Y; Sun Q; Li X; Kuang E
    Genomics; 2021 Jul; 113(4):2591-2604. PubMed ID: 34087421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRLF1 suppresses RNA Pol III-mediated RIG-I inflammasome activation in the early EBV lytic lifecycle.
    Long X; Yang J; Zhang X; Yang Z; Li Y; Wang F; Li X; Kuang E
    EMBO Rep; 2021 Jan; 22(1):e50714. PubMed ID: 33225563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas.
    Jia Y; Wang Y; Chao Y; Jing Y; Sun Z; Luo B
    Virol J; 2010 Nov; 7():341. PubMed ID: 21106109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation.
    Hong Y; Holley-Guthrie E; Kenney S
    Virology; 1997 Mar; 229(1):36-48. PubMed ID: 9123876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.
    Quinlivan EB; Holley-Guthrie E; Mar EC; Smith MS; Kenney S
    J Virol; 1990 Apr; 64(4):1817-20. PubMed ID: 2157062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of transactivation activity of Rta of Epstein-Barr virus by RanBPM.
    Chang LK; Liu ST; Kuo CW; Wang WH; Chuang JY; Bianchi E; Hong YR
    J Mol Biol; 2008 May; 379(2):231-42. PubMed ID: 18455188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.
    Feederle R; Kost M; Baumann M; Janz A; Drouet E; Hammerschmidt W; Delecluse HJ
    EMBO J; 2000 Jun; 19(12):3080-9. PubMed ID: 10856251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication.
    LaJeunesse DR; Brooks K; Adamson AL
    Biochem Biophys Res Commun; 2005 Jul; 333(2):438-42. PubMed ID: 15950179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence analysis of EBV immediate-early gene BZLF1 and BRLF1 in lymphomas.
    Yang Y; Jia Y; Wang Y; Wang X; Sun Z; Luo B
    J Med Virol; 2014 Oct; 86(10):1788-95. PubMed ID: 24615673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent.
    Zhang L; Chiu J; Lin JC
    DNA Cell Biol; 1998 Sep; 17(9):735-42. PubMed ID: 9778032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.